Evidence map›Paper›PMID 20622026›Full record

ArticleAmerican journal of respiratory and critical care medicine2010

Loss of cystic fibrosis transmembrane conductance regulator function produces abnormalities in tracheal development in neonatal pigs and young children.

David K Meyerholz, David A Stoltz, Eman Namati, Shyam Ramachandran, Alejandro A Pezzulo, Amanda R Smith, Michael V Rector, Melissa J Suter, Simon Kao, Geoffrey McLennan and 4 more

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 199 citations in OpenAlex.

  1. Antiviral defenses are diminished at birth in cystic fibrosis pig airways.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2026
    Article
  2. Considerations for early life genetic therapies in cystic fibrosis.American journal of physiology. Lung cellular and molecular physiology · 2026
    Review
  3. Progenitor Resilience and the Early Onset of Chronic Lung Diseases: NHLBI workshop report.American journal of respiratory cell and molecular biology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Genome-wide association study of susceptibility toThe European respiratory journal · 2024
    Article
  11. Considerations for the use of inhaled antibiotics forBMJ open respiratory research · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. ACS pharmacology & translational science · 2023
    Review
  19. Article
  20. Review

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

David K MeyerholzDepartment of Pathology, University of Iowa, Iowa City, 52242, USA. david-meyerholz@uiowa.edu
David A Stoltz
Eman Namati
Shyam Ramachandran
Alejandro A Pezzulo
Amanda R Smith
Michael V Rector
Melissa J Suter
Simon Kao
Geoffrey McLennan
Guillermo J Tearney
Joseph Zabner
Paul B McCray
Michael J Welsh
University of Iowa · USHarvard University · USPediatrics and Genetics · US

Funding

Vector CoreP01HL051670 · NHLBI · UNIVERSITY OF IOWA · PI MCCRAY, PAUL B · 1993 to 2019
$36.5M
Respiratory virus infection in early cystic fibrosis lung diseaseP01HL091842 · NHLBI · UNIVERSITY OF IOWA · PI STOLTZ, DAVID A · 2008 to 2022
$34.2M
Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Alejandro Antonio Pezzulo · 1998 to 2026
$30.5M
Paraoxonase-2 S311C Polymorphism Alters Glycosylation and Lactonase ActivityK08AI076671 · NIAID · UNIVERSITY OF IOWA · PI STOLTZ, DAVID A · 2008 to 2011
$605k
NHLBI NIH HHS HL091842NHLBI NIH HHS HL51670NIAID NIH HHS AI076671NIDDK NIH HHS DK54759NIDDK NIH HHS P30 DK054759
6 · The paper itself

Abstract

rationaleAlthough airway abnormalities are common in patients with cystic fibrosis (CF), it is unknown whether they are all secondary to postnatal infection and inflammation, which characterize the disease.

objectivesTo learn whether loss of the cystic fibrosis transmembrane conductance regulator (CFTR) might affect major airways early in life, before the onset of inflammation and infection.

methodsWe studied newborn CFTR⁻(/)⁻ pig trachea, using computed tomography (CT) scans, pathology, and morphometry. We retrospectively analyzed trachea CT scans in young children with CF and also previously published data of infants with CF. MEASUREMENTS AND MAIN

resultsWe discovered three abnormalities in the porcine CF trachea. First, the trachea and mainstem bronchi had a uniformly small caliber and cross-sections of trachea were less circular than in controls. Second, trachealis smooth muscle had an altered bundle orientation and increased transcripts in a smooth muscle gene set. Third, submucosal gland units occurred with similar frequency in the mucosa of CF and control airways, but CF submucosal glands were hypoplastic and had global reductions in tissue-specific transcripts. To learn whether any of these changes occurred in young patients with CF, we examined CT scans from children 2 years of age and younger, and found that CF tracheas were less circular in cross-section, but lacked differences in lumen area. However, analysis of previously published morphometric data showed reduced tracheal lumen area in neonates with CF.

conclusionsOur findings in newborn CF pigs and young patients with CF suggest that airway changes begin during fetal life and may contribute to CF pathogenesis and clinical disease during postnatal life.

Indexed as

AnimalsAnimals, NewbornChild, PreschoolCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorHumansInfantMicroarray AnalysisMuscle, SmoothRespiratory MucosaRetrospective StudiesSwineTomography, X-Ray ComputedTracheaCystic Fibrosis Transmembrane Conductance Regulator

Identifiers

PMID20622026
PMCPMC3001264
OpenAlexW2045776266

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.